Construction and Analysis of the NCI-EDRN Breast Cancer Reference Set for Circulating Markers of Disease
- 1 February 2015
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 24 (2) , 435-441
Abstract
Background: Many circulating biomarkers have been reported for the diagnosis of breast cancer, but few, if any, have undergone rigorous credentialing using prospective cohorts and blinded evaluation. Methods: The NCI Early Detection Research Network (EDRN) has created a prospective, multicenter collection of plasma and serum samples from 832 subjects designed to evaluate circulating biomarkers for the detection and diagnosis of breast cancer. These samples are available to investigators who wish to evaluate their biomarkers using a set of blinded samples. The breast cancer reference set is composed of blood samples collected using a standard operating procedure at four U.S. medical centers from 2008 to 2010 from women undergoing either tissue diagnosis for breast cancer or routine screening mammography. The reference set contains samples from women with incident invasive cancer (n = 190), carcinoma in situ (n = 55), benign pathology with atypia (n = 63), benign disease with no atypia (n = 231), and women with no evidence of breast disease by screening mammography (BI-RADS 1 or 2, n = 276). Using a subset of plasma samples (n = 505) from the reference set, we analyzed 90 proteins by multiplexed immunoassays for their potential utility as diagnostic markers. Results: We found that none of these markers is useful for distinguishing cancer from benign controls. However, elevated CA-125 does appear to be a candidate marker for estrogen receptor–negative cancers. Conclusions: Markers that can distinguish benign breast conditions from invasive cancer have not yet been found. Impact: Availability of prospectively collected samples should improve future validation efforts. Cancer Epidemiol Biomarkers Prev; 24(2); 435–41. ©2014 AACR.Keywords
All Related Versions
This publication has 21 references indexed in Scilit:
- The Early Detection Research Network's Specimen Reference Sets: Paving the Way for Rapid Evaluation of Potential BiomarkersClinical Chemistry, 2013
- The Long Journey of Cancer Biomarkers from the Bench to the ClinicClinical Chemistry, 2013
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Modeling the impact of population screening on breast cancer mortality in the United StatesThe Breast, 2011
- Do serum biomarkers really measure breast cancer?BMC Cancer, 2009
- Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study DesignJNCI: Journal of the National Cancer Institute, 2008
- Pooling of Case Specimens to Create Standard Serum Sets for Screening Cancer BiomarkersCancer Epidemiology, Biomarkers & Prevention, 2007
- Ethnic differences in circulating soluble adhesion molecules: the Wandsworth Heart and Stroke StudyClinical Science, 2003
- Elevated C-Reactive Protein Levels in Overweight and Obese AdultsJAMA, 1999
- Increase in Circulating Levels of Monocyte Chemoattractant Protein-1 with AgingJournal of Interferon & Cytokine Research, 1999